FI66834C - Foerfarande foer framstaellning av terapeutiskt aktiva omega-dialkylalkansyrederivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva omega-dialkylalkansyrederivat Download PDF

Info

Publication number
FI66834C
FI66834C FI751888A FI751888A FI66834C FI 66834 C FI66834 C FI 66834C FI 751888 A FI751888 A FI 751888A FI 751888 A FI751888 A FI 751888A FI 66834 C FI66834 C FI 66834C
Authority
FI
Finland
Prior art keywords
acid
propyl
compounds
sodium
gaba
Prior art date
Application number
FI751888A
Other languages
English (en)
Finnish (fi)
Other versions
FI751888A (sv
FI66834B (fi
Inventor
Georges Marcel Taillandier
Andre Louis Boucherle
Jean-Louis Alain Benoit-Guyod
Pierre Luc Eymard
Madeleine Broll
Bernard Ferrandes
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of FI751888A publication Critical patent/FI751888A/fi
Application granted granted Critical
Publication of FI66834B publication Critical patent/FI66834B/fi
Publication of FI66834C publication Critical patent/FI66834C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C07C29/095Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of esters of organic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/60Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by elimination of -OH groups, e.g. by dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI751888A 1974-06-26 1975-06-26 Foerfarande foer framstaellning av terapeutiskt aktiva omega-dialkylalkansyrederivat FI66834C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2841674 1974-06-26
GB28416/74A GB1485269A (en) 1974-06-26 1974-06-26 Pharmaceutical compositions containing acetic acid derivatives

Publications (3)

Publication Number Publication Date
FI751888A FI751888A (sv) 1975-12-27
FI66834B FI66834B (fi) 1984-08-31
FI66834C true FI66834C (fi) 1984-12-10

Family

ID=10275286

Family Applications (1)

Application Number Title Priority Date Filing Date
FI751888A FI66834C (fi) 1974-06-26 1975-06-26 Foerfarande foer framstaellning av terapeutiskt aktiva omega-dialkylalkansyrederivat

Country Status (21)

Country Link
JP (1) JPS6041058B2 (sv)
AR (2) AR205748A1 (sv)
AT (1) AT341490B (sv)
CA (1) CA1041015A (sv)
CH (2) CH609668A5 (sv)
DE (1) DE2528025A1 (sv)
DK (1) DK288775A (sv)
ES (1) ES438905A1 (sv)
FI (1) FI66834C (sv)
FR (1) FR2276036A1 (sv)
GB (1) GB1485269A (sv)
HU (1) HU174772B (sv)
IE (1) IE42947B1 (sv)
IT (1) IT1049449B (sv)
NL (1) NL7507253A (sv)
NO (1) NO146905C (sv)
NZ (1) NZ177837A (sv)
OA (1) OA05039A (sv)
SE (2) SE427926B (sv)
YU (2) YU40439B (sv)
ZA (1) ZA753800B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558154B1 (fr) * 1984-01-16 1986-08-29 Pf Medicament Acides gras ramifies en c10 a c20 utiles en tant que medicaments, et leur procede de preparation
GB2323703B (en) * 1997-03-13 2002-02-13 United Microelectronics Corp Method to inhibit the formation of ion implantation induced edge defects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484486A (en) * 1946-05-15 1949-10-11 Eastman Kodak Co Preparation of carboxylic acids by the reduction of beta lactones
US2484500A (en) * 1947-10-28 1949-10-11 Eastman Kodak Co Preparation of propionic acids by reduction of beta propiono lactones
FR2442M (fr) * 1962-10-17 1964-04-06 Henry Eugene L'acide dipropylacétique et ses dérivés en tant que nouveuax médicaments dépresseurs du systeme nerveux central.

Also Published As

Publication number Publication date
SE435275B (sv) 1984-09-17
YU40439B (en) 1986-02-28
FR2276036B1 (sv) 1978-11-10
NO146905B (no) 1982-09-20
AU8239375A (en) 1977-01-06
FI751888A (sv) 1975-12-27
NL7507253A (nl) 1975-12-30
AR205748A1 (es) 1976-05-31
IE42947L (en) 1975-12-26
SE7507297L (sv) 1975-12-27
DK288775A (da) 1975-12-27
NO146905C (no) 1982-12-29
ATA487575A (de) 1977-06-15
YU41539B (en) 1987-08-31
ZA753800B (en) 1976-05-26
IT1049449B (it) 1981-01-20
JPS5129216A (en) 1976-03-12
CA1041015A (en) 1978-10-24
SE427926B (sv) 1983-05-24
NZ177837A (en) 1978-12-18
FR2276036A1 (fr) 1976-01-23
CH609668A5 (en) 1979-03-15
ES438905A1 (es) 1977-02-01
DE2528025A1 (de) 1976-01-15
SE7907843L (sv) 1979-09-21
YU162975A (en) 1983-09-30
OA05039A (fr) 1980-12-31
GB1485269A (en) 1977-09-08
IE42947B1 (en) 1980-11-19
NO752270L (sv) 1975-12-30
AT341490B (de) 1978-02-10
FI66834B (fi) 1984-08-31
YU59883A (en) 1983-12-31
AR212236A1 (es) 1978-06-15
CH609667A5 (en) 1979-03-15
HU174772B (hu) 1980-03-28
JPS6041058B2 (ja) 1985-09-13

Similar Documents

Publication Publication Date Title
US4244968A (en) Treatment of arthritis and substances for use in such treatment
JPS59118750A (ja) カルボン酸アミド化合物およびその誘導体
IL228630A (en) Compounds for the treatment of metabolic syndrome and intermediates for the synthesis of these compounds
KR101736416B1 (ko) 고혈압 및/또는 섬유화 치료용 조성물
JPS5910584A (ja) イミダゾリジン誘導体
US4025649A (en) Acetic acid derivatives having pharmacological activity and compositions containing the same
FI66834C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva omega-dialkylalkansyrederivat
AU2020276005B2 (en) 3-aryloxyl-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof
Samhoun et al. Actions and interactions of lipoxygenase and cyclo-oxygenase products in respiratory and vascular tissues
HUT63843A (en) Process for producing new kumarin derivatives and their analogs inhibiting mammal cell proliferation and tumour growth, as well as pharmaceutical comkpositions comprising such compounds
EP2207766A1 (en) Novel sulfamate compounds for medical use
US3746495A (en) Anti-ulcer therapy
CN113105409B (zh) 2-(羟基苄基)苯并[d]异噻唑酮类化合物、其制备方法和用途
US3870792A (en) Certain dihydrophthalizines for treating hemorrhage and thrombosis
US3551576A (en) Anti-fibrinolytic agent
JPH0514708B2 (sv)
JPH04368359A (ja) カプサイシン誘導体又はその酸エステルを有効成分とする鎮痛剤、血管拡張剤
US4055648A (en) Papaverine thienyl-carboxylates and medicaments containing them
Gadekar et al. Synthesis and biological activity of pyridoxine analogs
JP2021512958A (ja) 神経変性疾患を治療するための医薬及びその使用
JPH0115501B2 (sv)
CH641775A5 (fr) N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment.
CN113304129B (zh) 单烯酮类单羰基姜黄素类似物在制备抗氧化药物的应用
CA3140231C (en) 3-aryloxyl-3-five-membered heteroaryl-propylamine compound, and crystal form and use thereof
EP1507523A1 (en) Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANOFI